235 related articles for article (PubMed ID: 23999367)
1. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Metabolic bone disease and fracture induced by drugs].
Suzuki H
Clin Calcium; 2013 Sep; 23(9):1307-12. PubMed ID: 23999367
[TBL] [Abstract][Full Text] [Related]
2. [Drug-induced osteoporosis].
Briot K
Rev Prat; 2012 Feb; 62(2):187-92. PubMed ID: 22408857
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced osteoporosis: mechanisms and clinical implications.
Mazziotti G; Canalis E; Giustina A
Am J Med; 2010 Oct; 123(10):877-84. PubMed ID: 20920685
[TBL] [Abstract][Full Text] [Related]
4. Drug-induced osteoporosis: from Fuller Albright to aromatase inhibitors.
Byreddy DV; Bouchonville MF; Lewiecki EM
Climacteric; 2015; 18 Suppl 2():39-46. PubMed ID: 26488130
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
Fournier MR; Targownik LE; Leslie WD
Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
[TBL] [Abstract][Full Text] [Related]
6. [Drug induced osteoporosis].
Zofková I
Vnitr Lek; 2013 Jan; 59(1):59-63. PubMed ID: 23565522
[TBL] [Abstract][Full Text] [Related]
7. Drugs that may harm bone: Mitigating the risk.
Hant FN; Bolster MB
Cleve Clin J Med; 2016 Apr; 83(4):281-8. PubMed ID: 27055202
[TBL] [Abstract][Full Text] [Related]
8. [Secondary osteoporosis or secondary contributors to bone loss in fracture. Therapeutic strategy for glucocorticoid-induced osteoporosis].
Hayakawa N; Suzuki A
Clin Calcium; 2013 Sep; 23(9):1337-44. PubMed ID: 23999371
[TBL] [Abstract][Full Text] [Related]
9. [Secondary osteoporosis or secondary contributors to bone loss in fracture. causes and pathophysiology of secondary osteoporosis].
Yamauchi M; Sugimoto T
Clin Calcium; 2013 Sep; 23(9):1251-7. PubMed ID: 23999359
[TBL] [Abstract][Full Text] [Related]
10. Drug-induced bone loss: a major safety concern in Europe.
Nguyen KD; Bagheri B; Bagheri H
Expert Opin Drug Saf; 2018 Oct; 17(10):1005-1014. PubMed ID: 30222369
[TBL] [Abstract][Full Text] [Related]
11. Medication-induced osteoporosis.
Weng MY; Lane NE
Curr Osteoporos Rep; 2007 Dec; 5(4):139-45. PubMed ID: 18430387
[TBL] [Abstract][Full Text] [Related]
12. [Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?].
Maléth J; Hegyi P
Orv Hetil; 2013 Jun; 154(26):1005-9. PubMed ID: 23800385
[TBL] [Abstract][Full Text] [Related]
13. A review of the effect of anticonvulsant medications on bone mineral density and fracture risk.
Lee RH; Lyles KW; Colón-Emeric C
Am J Geriatr Pharmacother; 2010 Feb; 8(1):34-46. PubMed ID: 20226391
[TBL] [Abstract][Full Text] [Related]
14. [Fracture risk associated with drugs other than glucocorticoids].
Okazaki R
Clin Calcium; 2014 Mar; 24(3):357-65. PubMed ID: 24576932
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced osteoporosis.
Berris KK; Repp AL; Kleerekoper M
Curr Opin Endocrinol Diabetes Obes; 2007 Dec; 14(6):446-50. PubMed ID: 17982350
[TBL] [Abstract][Full Text] [Related]
16. Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer.
Smith MR; Lee WC; Brandman J; Wang Q; Botteman M; Pashos CL
J Clin Oncol; 2005 Nov; 23(31):7897-903. PubMed ID: 16258089
[TBL] [Abstract][Full Text] [Related]
17. [Non-corticosteroid drug-induced metabolic bone disease].
Briot K
Presse Med; 2006 Oct; 35(10 Pt 2):1579-83. PubMed ID: 17028524
[TBL] [Abstract][Full Text] [Related]
18. Emerging drugs for the management of cancer treatment induced bone loss.
Bertoldo F; Pancheri S; Zenari S; Boldini S
Expert Opin Emerg Drugs; 2010 Jun; 15(2):323-42. PubMed ID: 20377485
[TBL] [Abstract][Full Text] [Related]
19. [Antiepileptic drug-induced osteopathy. Subtypes, pathogenesis, prevention, early diagnosis and treatment].
Bartl R
Dtsch Med Wochenschr; 2007 Jul; 132(27):1475-9. PubMed ID: 17583832
[TBL] [Abstract][Full Text] [Related]
20. [On "2015 Guidelines for Prevention and Treatment of Osteoporosis". Medication-related osteoporosis: others].
Suzuki A; Ueda SS; Kakita A
Clin Calcium; 2015 Sep; 25(9):1367-72. PubMed ID: 26320537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
